Adaptive Biotechnologies, Microsoft ImmuneCode COVID-19 Database
Adaptive Biotechnologies and Microsoft have launched ImmuneCode, an open database related to the immune response of individuals with COVID-19. The deidentified data contains information on T cells shown to recognize antigens of the SARS-CoV-2 virus, obtained from blood samples. It provides a population-level view into the adaptive immune response; samples have been drawn from geographically and ethnically diverse patients as part of Adaptive's ImmuneRace study. The data will be freely available to any researcher, public health official, or organization around the world, Adaptive said.